Description
This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 5
Primary Industries
- Medical
- Device
- obesity
- Surgical
- Drugs
- Biotechnology
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 237382
License Grant
Assignor, a stockholder, assigned its interest in the products and patents.
License Property
US10513583 – Balloon system and methods for treating obesity
Field of Use
The Assignee is an early-stage medical device company that has developed and is commercializing a unique non-surgical product for the treatment of obesity.
IPSCIO Record ID: 229364
License Grant
With the assignment agreement, Assignor, a stockholder, assigned its interest in the products and patents. The amendment clarifies the patents included.
License Property
The patents are for Gastric space filler device, delivery system and related methods, and, intragastric space fillers, and, Intragastric Balloon System and therapeutic processed and products.
Field of Use
The Assignee is an early-stage medical device company that has developed and is commercializing a unique non-surgical product for the treatment of obesity.
IPSCIO Record ID: 352092
License Grant
Assignor assigned its entire right, title, and interest in the Innovation to Assignee.
To the extent Assignee grants a license of the Innovation, or any part thereof, to any third party, and receives Revenue therefrom, then Assignee agrees to pay to Assignor a percentage of Revenue received in the aggregate by Assignee from all such licensees granting rights to the Innovation, distributed by Assignee.
License Property
Assignor assigned its entire right, title, and interest in the Assigned Patent Applications, inventions and improvements therein, and Letters Patent (referred to herein collectively as the “Innovationâ€) to Assignee via that certain Assignment recorded with the United States Patent and Trademark Office on November 16, 2016 at reel and frame number 040337/0243.
Field of Use
Field of use is for the medical industry.
Assignee is a developer of rapid health information technologies.
IPSCIO Record ID: 3608
License Grant
Assignor, an individual, desires to sell, assign, transfer and convey to Assignee, its successors and assigns, Assignor's entire right, title and interest throughout the world in and to the Patent Application and patents issuing thereon to the full end of the term or terms of any said patents.
License Property
Assignor has made certain inventions relating to chimeric peptides.
Product shall mean all products, drugs, diagnostic reagents, diagnostic methods, therapeutic agents and therapeutic methods covered in whole or in part by a Valid Claim contained in any Patent.
Field of Use
Inventions and patent applications relate to the use of chimeric peptides for the treatment of Alzheimer’s disease.
IPSCIO Record ID: 25890
License Grant
The Licensor assigned the patent rights relating to International Patent Application No. PCT/IB2012/001470 to the Licensee of in Hong Kong. Licensor is the beneficial stockholder of Licensee.
License Property
International Patent Application No. PCT/IB2012/001470 entitled Pain Management Device.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.
